UCB
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch UCB and buy or sell other stocks, ETFs, and their options commission-free!About UCBJY
UCB SA engages in the research and development of biopharmaceuticals products. It offers medicinal products such as briviact, keppra, vimpat, neupro, cimzia, nootropil, xyrem, xyzal, and zyrtec.
CEOJean-Christophe Tellier
CEOJean-Christophe Tellier
Employees9,378
Employees9,378
HeadquartersBrussels, Brussels Region
HeadquartersBrussels, Brussels Region
Founded1925
Founded1925
Employees9,378
Employees9,378
UCBJY Key Statistics
Market cap56.04B
Market cap56.04B
Price-Earnings ratio37.87
Price-Earnings ratio37.87
Dividend yield0.34%
Dividend yield0.34%
Average volume20.16K
Average volume20.16K
High today$148.85
High today$148.85
Low today$142.55
Low today$142.55
Open price$148.55
Open price$148.55
Volume3.79K
Volume3.79K
52 Week high$151.76
52 Week high$151.76
52 Week low$71.16
52 Week low$71.16
Stock Snapshot
UCB(UCBJY) stock is priced at $144.05, giving the company a market capitalization of 56.04B. It carries a P/E multiple of 37.87 and pays a dividend yield of 33.6%.
As of 2025-12-06, UCB(UCBJY) stock has fluctuated between $142.55 and $148.85. The current price stands at $144.05, placing the stock +1.1% above today's low and -3.2% off the high.
UCB(UCBJY) shares are trading with a volume of 3.79K, against a daily average of 20.16K.
In the last year, UCB(UCBJY) shares hit a 52-week high of $151.76 and a 52-week low of $71.16.
In the last year, UCB(UCBJY) shares hit a 52-week high of $151.76 and a 52-week low of $71.16.
Analyst ratings
74%
of 19 ratingsBuy
73.7%
Hold
15.8%
Sell
10.5%